Drug Shortage Report for OMNISCAN

Last updated on 2021-05-29 History
Report ID 132721
Drug Identification Number 02172771
Brand name OMNISCAN
Common or Proper name Gadodiamide injection USP
Company Name GE HEALTHCARE CANADA INC
Market Status MARKETED
Active Ingredient(s) GADODIAMIDE
Strength(s) 287MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 mL vials
ATC code V08CA
ATC description MAGNETIC RESONANCE IMAGING CONTRAST MEDIA
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2021-02-16
Actual start date 2021-02-16
Estimated end date 2021-05-31
Actual end date 2021-05-28
Shortage status Resolved
Updated date 2021-05-29
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1919 MINNESOTA COURT
MISSISSAUGA, ONTARIO
CANADA L5N 0C9
Company contact information 800-387-7146 canadainfo@gehealthcare.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-01-29 English Compare
v2 2021-01-29 French Compare
v3 2021-01-29 English Compare
v4 2021-01-29 French Compare
v5 2021-02-09 English Compare
v6 2021-02-10 English Compare
v7 2021-02-10 French Compare
v8 2021-02-16 English Compare
v9 2021-02-16 French Compare
v10 2021-02-17 English Compare
v11 2021-02-25 English Compare
v12 2021-02-25 French Compare
v13 2021-03-31 English Compare
v14 2021-03-31 French Compare
v15 2021-05-28 English Compare
v16 2021-05-28 French Compare
v17 2021-05-29 English Compare

Showing 1 to 17 of 17